CSC
CELU icon

Caldwell Sutter Capital’s Celularity CELU Stock Holding History

Caldwell Sutter Capital’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33K Hold
1,000
– – ﹤0.01% 792
2025
Q4 		$1.11K Hold
1,000
– – ﹤0.01% 798
2025
Q3 		$2.07K Buy
+1,000
New +$2.8K ﹤0.01% 738

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

Caldwell Sutter Capital's CELU Position: Q1 2026 in Review

Caldwell Sutter Capital held its Celularity (CELU) position steady in Q1 2026 at 1,000 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #792.

Caldwell Sutter Capital first reported a position in CELU in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.07K in Q3 2025. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Caldwell Sutter Capital held 1,000 shares of Celularity worth $1.33K as of Q1 2026.
  • Caldwell Sutter Capital left its Celularity share count unchanged in Q1 2026.
  • Celularity made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q1 2026, its #792 holding.
  • Caldwell Sutter Capital first reported a position in Celularity in Q3 2025 and has held it in 3 quarters since.
  • Caldwell Sutter Capital's Celularity position peaked at $2.07K in Q3 2025.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Caldwell Sutter Capital's 13F filing for Q1 2026, filed 6 May 2026.